title: Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia.
abstract: The usage of the immunoglobulin (Ig) V(H)3-21 gene is associated with poor prognosis in B-cell chronic lymphocytic leukemia (B-CLL) despite V(H) gene mutation status. Many V(H)3-21+ patients also display restricted heavy- and light-chain Ig gene rearrangements, implying a role of antigen selection in disease development. To explore the specific phenotypic/genotypic features among V(H)3-21+ B-CLLs, we compared gene expression patterns in 15 V(H)3-21+ and 24 non-V(H)3-21 patients (11 with unmutated and 13 with mutated V(H) genes) using Affymetrix microarray analysis (approximately 12,500 genes). A distinct expression profile was identified for V(H)3-21+ patients in contrast to the Ig-unmutated and -mutated groups. By applying different algorithms, the data enabled an efficient class discrimination of the V(H)3-21+ subset based on 27 or 57 genes. A set of genes was sorted out which, using different analytical methods, consistently gave a distinction between V(H)3-21+ and non-V(H)3-21 samples. Several of these genes are involved in regulation of DNA replication/cell-cycle control, transcription and protein kinase activity, which may render the V(H)3-21+ cells with a higher proliferative drive. However, no clear evidence of increased B-cell receptor signaling was found in the V(H)3-21+ group. Altogether, our identification of a specific V(H)3-21 profile may provide insights into the pathogenesis of the V(H)3-21+ subgroup.
authors.affiliation: Unit of Environmental Medicine, Center for Nutrition and Toxicology, Department of Biosciences at Novum, Karolinska Institutet, SE-14157 Huddinge, Sweden. susann.falt@biosci.ki.se
authors.forename: Susann
authors.initials: S
authors.lastname: Fält
authors.forename: Mats
authors.initials: M
authors.lastname: Merup
authors.forename: Gerard
authors.initials: G
authors.lastname: Tobin
authors.forename: Ulf
authors.initials: U
authors.lastname: Thunberg
authors.forename: Gösta
authors.initials: G
authors.lastname: Gahrton
authors.forename: Richard
authors.initials: R
authors.lastname: Rosenquist
authors.forename: Anders
authors.initials: A
authors.lastname: Wennborg
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000465:Algorithms; D002453:Cell Cycle; D005260:Female; D020869:Gene Expression Profiling / Q000706:statistics & numerical data; D015326:Gene Rearrangement, B-Lymphocyte, Heavy Chain; D005838:Genotype; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics* / Q000276:immunology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D020411:Oligonucleotide Array Sequence Analysis / Q000706:statistics & numerical data; D010641:Phenotype; D011379:Prognosis; D011947:Receptors, Antigen, B-Cell / Q000378:metabolism; D015398:Signal Transduction; D027041:Somatic Hypermutation, Immunoglobulin; D014158:Transcription, Genetic
chemical_list: D011947:Receptors, Antigen, B-Cell